Skip to main content
NACFC 2025 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Session includes invitee/speaker with CF. Others with CF encouraged to participate virtually.
Session includes invitee/speaker with CF. Others with CF encouraged to participate virtually.
Livestreamed Session
Livestreamed Session

APPTT
Session Type: Rapid-Fire Poster Talk

RFPT01--Therapeutic Targeting of Inflammation in CF

Thursday, October 23, 2025
9:00 AM - 9:50 AM PDT
Location:Theater B Exhibit Hall

Attendees will learn the latest novel science tackling pathways of aberrant inflammation in people with cystic fibrosis, using a variety of model systems. Session will feature rapid fire poster talks and interactive discussions.

Learning Objectives:

  • N/A
  • N/A
  • N/A

Presentations:

  • 9:00 AM - 9:50 AM PDT
    Long term effects of elexacaftor/tezacaftor/ivacaftor on airway and systemic inflammation in cystic fibrosis over a five-year period 

    Speaker: Eamon Maurice Mullen, N/A, MBBCHBAO – Royal college of surgeons in Ireland

  • 9:00 AM - 9:50 AM PDT
    PDE4 Inhibitor Apremilast Rebalances Inflammatory Responses to Pseudomonas aeruginosa Infection in CF Rats

    Speaker: Linto Antony, n/a – University of Alabama at Birmingham

  • 9:00 AM - 9:50 AM PDT
    IL-21 and IL-21R interaction plays a key role in mounting humoral and cell-mediated immune response to adenoviral and adeno-associated viral vectors in lung

    Speaker: Mina R. Hanna, n/a – Tulane University School of Medicine

  • 9:00 AM - 9:50 AM PDT
    KIT2014, a clinical-stage inhaled PDE3/4 inhibitor to target airway neutrophilic inflammation and CFTR dysfunction.

    Speaker: Valentina Sala, PhD – Kither Biotech

  • 9:00 AM - 9:50 AM PDT
    Chronic Lung Inflammation in Cystic Fibrosis Drives Maladaptive Trained Tmmunity in Hematopoietic Stem Cells

    Speaker: Cassia Braga – Yale School of Medicine

  • 9:00 AM - 9:50 AM PDT
    Targeting microRNAs as anti-inflammatory therapeutics for cystic fibrosis lung disease

    Speaker: Roopa Biswas, Ph.D. – Uniformed Services University

  • 9:00 AM - 9:50 AM PDT
    Assessing infection and inflammation in cystic fibrosis through exhaled breath: A longitudinal study

    Speaker: Josephine Ackah-Cudjoe, n/a – University of British Columbia

  • 9:00 AM - 9:50 AM PDT
    Effects of environmental and social epidemiological factors on cytokine response in people with cystic fibrosis

    Speaker: Maria Ansar, MD-PhD – Cincinnati Children's Hospital Center